|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K2317/24 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 14/51 | (2013.01) | ||
| C12N 15/63 | (2006.01) | ||
| C07K 16/22 | (2013.01) | ||
| A61P 15/12 | (2018.01) | ||
| A61P 15/12 | (2006.01) | ||
| C07K 14/51 | (2006.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 19/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| C12N 15/63 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 2345668 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10014360.1 |
| Europos patento paraiškos padavimo data | 2006-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 677583 P | 2005-05-03 | US | |
| 776847 P | 2006-02-24 | US | |
| 782244 P | 2006-03-13 | US | |
| 792645 P | 2006-04-17 | US | |
| 410540 | 2006-04-25 | US |
| (72) |
Lu, Hsieng Sen , US
Paszty, Christopher , US
Robinson, Martyn Kim , GB
Henry, Alistair James , GB
Hoffmann, Kelly Sue , US
Latham, John , US
Lawson, Alastair , GB
Winkler, David , US
Winters, Aaron George , US
|
| (73) |
UCB Pharma, S.A. ,
Allée de la Recherche 60, 1070 Bruxelles,
BE
Amgen, Inc. , One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US |
| (54) | SCLEROSTIN EPITOPES |
| SCLEROSTIN EPITOPES |